Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
BRII-196
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
rlcv-miR-rL1-28-3p
Potential treatment - pre-clinical evidence Natural product Antiviral May/10/2021
Soybean Trypsin Inhibitor
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021
Full-length Spike protein
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/29/2021
Bortezomib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/12/2021
Lurasidone
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021
Elbasvir
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021
STE73-2E9
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/11/2021
Emetine
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021
Avoralstat
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/12/2021
Neferine
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021
Adjuvanted SARS-CoV-2 Spike protein
Potential treatment - pre-clinical evidence Experimental Vaccine Apr/01/2021
Oleandrin
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/03/2021
Nerium oleander extract
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/03/2021
4-[2-(2-Benzyloxycarbonylamino-3-t-butoxy-butyrylamino)-4-methyl-pentanoylamino]-5-(2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021
Tetrandrine
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/23/2021
Ginkgolic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/28/2021
Azanitrile 8
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
Pyridyl ester 17
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
Hypothiocyanite
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/19/2021